# OnCo record martin-schlumberger (person). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/people/martin-schlumberger/>
  a schema:Person ;
  onco:kind "person" ;
  schema:identifier "martin-schlumberger" ;
  schema:name "Martin Schlumberger"@en ;
  schema:description "Led SELECT (lenvatinib) and the ESTIMABL trials that showed many thyroid cancer patients can have lower radioiodine doses or none at all."@en ;
  schema:url <https://onco.cc/people/martin-schlumberger/> ;
  schema:dateModified "2026-09-10"^^xsd:date ;
  schema:citation <https://pubmed.ncbi.nlm.nih.gov/?term=Schlumberger%20M%5BAuthor%5D%20thyroid> ;
  onco:tag "thyroid", "radioiodine", "de-escalation" ;
  schema:jobTitle "Emeritus Professor of Oncology, Gustave Roussy and Université Paris-Saclay" ;
  onco:cancers <https://onco.cc/cancers/thyroid/> ;
  onco:technologies <https://onco.cc/technologies/radioligand-therapy/>, <https://onco.cc/technologies/kinase-inhibitors/> ;
  onco:institutions <https://onco.cc/institutions/gustave-roussy/> ;
  onco:trials <https://onco.cc/trials/select-lenvatinib/>, <https://onco.cc/trials/estimabl2/> ;
  schema:affiliation <https://onco.cc/institutions/gustave-roussy/> .